Biotechnology News

September 2, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), an innovative health care company that develops wearable medical technology and point-of-care tests to help patients and physicians manage chronic pain, nerve diseases, and sleep...

September 2, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm (NASDAQ:FLDM) announced that CEO Gajus Worthington will present at the Morgan Stanley Global Healthcare Conference in New York City on Tuesday, September 9, 2014 at 4:05 p.m. (ET).

September 2, 2014

NEW YORK--(BUSINESS WIRE)--Genome Engineering & CART Cells: At the forefront of immuno-oncology
R&D/ Analyst Day on September 11th at Le Parker Meridien Hotel in New York City

September 2, 2014

LYON, France--(BUSINESS WIRE)--Regulatory News : ERYTECH (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology...

September 2, 2014

DALY CITY, Calif.--(BUSINESS WIRE)--Recently Becker’s Healthcare, a prominent trade publication based in Chicago, recognized Dr. Paul Slosar, M.D., as a 2014 Leadership Award winner. Dr. Slosar is president of SpineCare Medical Group in Daly City...

September 2, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--XenoPort, Inc. (Nasdaq:XNPT) announced today that it will provide access via the World Wide Web to its presentation at the Morgan Stanley Global Healthcare Conference. The live presentation will occur at 1:40...

September 2, 2014

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb to Take Part in Morgan Stanley Global Health Care Conference

September 2, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Federally-funded novel video game launched by NERI as fun way to teach teens about clinical trials.

September 2, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna will attend the FBR Inaugural Healthcare Conference on Sept. 3, 2014 and present at the Baird 2014 Health Care Conference on Sept. 4, 2014.

September 2, 2014

DEERFIELD, Ill.--(BUSINESS WIRE)--Lundbeck announced today that NORTHERA™ (droxidopa) capsules for oral use are now available for healthcare providers to prescribe in the United States.

September 2, 2014

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. ("ACT"; OTCBB: ACTCD), a leader in the field of regenerative medicine, announced today the addition of five leading scientists to its new Scientific Advisory Board. The Board...

September 2, 2014

OXFORD, England--(BUSINESS WIRE)--CN Bio Innovations has today announced that new data generated in collaboration with Imperial College using its biologically relevant in vitro model will be presented at prestigious upcoming meetings.

September 2, 2014

LEUVEN, Belgium--(BUSINESS WIRE)--A 3D Printed Breakthrough for Complex Children’s Fractures: “I had a child with a handicap; now I have a normally functioning son.”

September 2, 2014

DENVER--(BUSINESS WIRE)--Exhibitors will be showcasing new technologies, products and services for 300+ attendees at the 2014 BioWest Conference & Expo, September 10, at the Marriott City Center, Denver.

September 2, 2014

BILLERICA, Mass.--(BUSINESS WIRE)--EMD Serono Research and Development Institute, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, entered into a collaborative research agreement with Massachusetts General Hospital (MGH)

September 2, 2014

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that management will present at the Morgan Stanley Global Healthcare Conference on Tuesday, September 9, 2014, at 1:30 p.m. Eastern Time. The presentation will...

September 2, 2014

HORSHAM, Pa.--(BUSINESS WIRE)--Galleon Pharmaceuticals announced clinically and statistically significant (p<0.01) results from a double-blind, placebo-controlled clinical proof-of-concept study of its lead investigational compound GAL-021 in...

September 2, 2014

SAN DIEGO--(BUSINESS WIRE)--ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in neurological and related central...

September 2, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Promedior Receives U.S. Orphan Drug Designation for PRM-151 for the Treatment of Myelofibrosis, a serious, life-limiting cancer characterized by fibrosis of the bone marrow.

September 2, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Morgan Stanley Global Healthcare Conference...

September 2, 2014

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Understanding the Brain’s Pulse Shows
Promise for Managing Concussion

Study data published in Clinical Journal of Sport Medicine

September 2, 2014

WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck to Present New Data in Five Tumor Types from Studies Evaluating Pembrolizumab, the Company’s Investigational Anti-PD-1 Antibody, at ESMO 2014

September 2, 2014

INGELHEIM, Germany--(BUSINESS WIRE)--Non-US/Non-UK/Non-Canadian Media New data presented today indicate that kidney function decline is less pronounced in patients with an irregular heartbeat (non-valvular atrial fibrillation, NVAF) who are...

September 2, 2014

IRVINE, Calif. and AMSTERDAM--(BUSINESS WIRE)--A new study reports that the BluePrint genomic test provides more accurate information about the molecular subtype of a specific breast cancer, compared to the use of conventional pathology tests.

September 2, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--NephroGenex, Inc. (NASDAQ:NRX), a pharmaceutical company focused on the development of therapeutics to treat kidney disease, today announced that Chief Executive Officer, Pierre Legault will present...

September 2, 2014

SAN DIEGO & VANCOUVER, British Columbia--(BUSINESS WIRE)--Sophiris Bio Reports Completion of Enrollment in the "PLUS-1" Phase 3 Trial of PRX302 for Benign Prostatic Hyperplasia (BPH, enlarged prostate)

September 2, 2014

LUXEMBOURG--(BUSINESS WIRE)--ABL and Mayo Medical Laboratories join forces to develop a deep-sequencing pipeline for novel diagnostic LDT with dedicated focus on clinical samples validation, sequences database and IT development

September 2, 2014

SAN DIEGO--(BUSINESS WIRE)--Cytori Therapeutics (NASDAQ: CYTX) has consolidated its EU operations to a new European office combined with a manufacturing facility in Deeside, Wales, UK.

September 2, 2014

IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc. (NYSE: AGN) announced today that the European Commission has extended the Marketing Authorization for OZURDEX® (dexamethasone 700 mcg intravitreal implant in applicator) to treat adult patients with...

September 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Tokai Pharmaceuticals Appoints Lee Kalowski as Chief Financial Officer

September 2, 2014

DANBURY, Conn.--(BUSINESS WIRE)--IMS Health (NYSE:IMS) today announced the immediate availability in the U.S. of IDN Impact — a first-of-its-kind solution to measure, compare and prioritize the influence of Integrated Delivery Networks (IDNs) on...

September 2, 2014

WAYNE, Pa.--(BUSINESS WIRE)--Teleflex to Present for the First Time at the 32nd Annual World Congress of Endourology and Shockwave Lithotripsy

September 2, 2014

NEW YORK--(BUSINESS WIRE)--David R. Guyer, M.D., CEO of Ophthotech Corp. will present an overview of the Company at the Morgan Stanley Global Healthcare Conference in New York City on Tues., Sept. 9, 2014 at 1:30 p.m. ET.

September 2, 2014

ALPHARETTA, Ga.--(BUSINESS WIRE)--Clearside Biomedical Inc. announces the closing of a $16 million Series B financing to fund continued development of its proprietary suprachoroidal space drug administration and clinical trials.

September 2, 2014

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today provided the financial community with guidance regarding the Company’s fiscal 2015 sales and earnings estimates. Based on the Company’s business...

September 2, 2014

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that Ron Cohen, M.D., President and Chief Executive Officer, and Andrew A. Hindman, Chief Business Development Officer, will present at the Morgan Stanley...

September 2, 2014

HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals to Present Corporate Update at the Morgan Stanley Global Healthcare Conference in New York City on September 9th

September 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--SAGE Therapeutics Presents New Preclinical Data on SAGE-217 at Eilat Conference on New Anti-Epileptic Drugs

September 2, 2014

SAN DIEGO--(BUSINESS WIRE)--OncoSec Medical to Present at Five Events in September

September 2, 2014

LOS ANGELES--(BUSINESS WIRE)--CytRx Corporation (Nasdaq:CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that President and CEO Steven A. Kriegsman and Vice President of Business Development...

September 2, 2014

MILAN--(BUSINESS WIRE)--First world implant of the CROWN PRT bioprosthetic aortic valve was performed in Austria at the Salzburg University Clinic.

September 2, 2014

MELBOURNE, Australia--(BUSINESS WIRE)--Specialty pharmaceutical company Hatchtech today announced positive results from its two pivotal Phase 3 clinical studies evaluating Xeglyze™ Lotion as a potential treatment for head lice infestation.

September 2, 2014

GALWAY, Ireland--(BUSINESS WIRE)--Neuravi will introduce the Neuravi Thromboembolic Initiative during a series of workshops on “The Science of Clot” at the ESMINT conference in Nice.

September 2, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today introduced ClearSeq AML, the first product in the ClearSeq line of next-generation cancer research panels, which targets 48 selected exons in 20 of the most commonly...

September 1, 2014

RYDALMERE, Australia--(BUSINESS WIRE)--Welch Allyn, a leading medical diagnostic device company that delivers pragmatic innovation at the point of care, today introduced the industry's most comprehensive clinical surveillance system designed...

September 1, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (NASDAQ:EXEL) today announced top-line results from the final analysis of COMET-1, the phase 3 pivotal trial of cabozantinib in men with metastatic castration-resistant prostate cancer...

September 1, 2014

LONDON & BOSTON & TOKYO--(BUSINESS WIRE)--Evaluate announced the appointment of Alex Karle to the role of Chief Executive Officer. Dr Jonathan de Pass, founder and Chief Executive Officer for the last 18 years, will become Chairman.

September 1, 2014

INGELHEIM, Germany--(BUSINESS WIRE)--For Non-US/Non-UK/Non-Canadian Media Five years on from the first breakthrough presentation of the pivotal RE-LY® clinical trial of Pradaxa® (dabigatran etexilate) for the prevention of stroke in non-valvular...